Cisplatin Injection, Solution
Product Images NDC 68001-608

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cisplatin (NDC 68001-608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisplatin Injection 100ml Carton Rev 102023 (Cisplatin Spl 100ml Carton)

Cisplatin Injection 100ml Carton Rev 102023 (Cisplatin Spl 100ml Carton)
Packaging label for CISPLATIN Injection 100 mg/100 mL (1 mg/mL) sterile solution for intravenous use. The label includes a warning to verify drug name and dose and highlights that doses greater than 100 mg/m2 are rarely used. The product is labeled as a cytotoxic agent and manufactured for BluePoint Laboratories. The label also states storage instructions and mentions the solution contains cisplatin USP and sodium chloride with pH adjustment.*
FDA Label Image

Cisplatin Injection 100ml Vial Labels Rev 102023 (Cisplatin Spl 100ml Vial)

Cisplatin Injection 100ml Vial Labels Rev 102023 (Cisplatin Spl 100ml Vial)
Label for CISplatin Injection 100 mg/100 mL (1 mg/mL) solution for intravenous use, a cytotoxic agent by BluePoint Laboratories. The 100 mL multiple dose vial label includes storage instructions, contents details, manufacturer Gland Pharma Limited (India), and a barcode. It also notes the product is sterile and not made with natural rubber latex.*
FDA Label Image

Cisplatin Injection 50ml Carton Rev 102023 (Cisplatin Spl 50ml Carton)

Cisplatin Injection 50ml Carton Rev 102023 (Cisplatin Spl 50ml Carton)
Packaging label for CISPLATIN Injection 50 mg/50 mL (1 mg/mL) sterile solution for intravenous use. The label includes warnings such as "Cytotoxic Agent" and dosage cautions. It is manufactured for BluePoint Laboratories by Gland Pharma Limited. The label features a STOP sign advising to verify drug name and dose, storage instructions, and a barcode.*
FDA Label Image

Cisplatin Injection 50ml Vial Labels Rev 102023 (Cisplatin Spl 50ml Vial)

Cisplatin Injection 50ml Vial Labels Rev 102023 (Cisplatin Spl 50ml Vial)
Label for CISplatin Injection 50 mg/50 mL (1 mg/mL) intravenous solution by BluePoint Laboratories. The label indicates it is a cytotoxic agent and multiple dose vial. It includes storage instructions, barcode, manufacturing information by Gland Pharma Limited, and a caution about dosage. The product is identified for sterile intravenous use.*
FDA Label Image

Cisplatin-spl-structure (Cisplatin Spl Structure)

Cisplatin-spl-structure (Cisplatin Spl Structure)
Chemical structure of Cisplatin showing a platinum (Pt) central atom bonded to two ammonia (NH3) groups and two chlorine (Cl) atoms arranged in a square planar geometry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.